(TSX-V:RVLY),(Boerse Frankfurt – Freiverkehr:9VK),(OTC US:RVLCF),(Other OTC:RVLCF), TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) today announced that its Board of Directors has approved a significant reduction in operating activity as the Company evaluates strategic alternatives in respect of its assets and operations. The Company is engaged in discussions […]

Rivalry Corp. Announces Significant Reduction in Operations and Evaluation of Strategic Alternatives GlobeNewswire February 13, 2026 TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) today announced that its Board of Directors has approved a significant reduction in operating activity as the Company evaluates strategic alternatives in respect of

Ashland, Massachusetts–(Newsfile Corp. – February 13, 2026) – HERS Rating Company, a Massachusetts-based HERS rating company, assists homeowners, builders, and developers in designing high-performance homes that reduce costs, meet the Massachusetts Stretch Energy Code, and lower carbon emissions. As energy codes tighten across the state, builders face rising construction costs and complex compliance requirements. The

London, UK – February 19, 2026 ?Precision Biologics, Inc. CEO Philip M. Arlen, MD gives a Keynote presentation describing in vitro?and?in vivo?efficacy of its novel tumor-specific antibody-drug-conjugate PB-223 ADC (PB-vcMMAE-5). Recent tumor killing data showing specific non-toxic anti-tumor activity in several human cancer types expressing truncated core 2 O-glycans will be reported in “PB-223, A

The global automotive industry is undergoing rapid transformation. At GAC, technological innovation remains at the core of our mission to deliver safer, more efficient, and more reliable mobility experiences for users worldwide. With proprietary core technologies, GAC is accelerating its global footprint and earning trust through quality–trust built on an unwavering commitment to high standards,

(AUST:AVH.AX),(NASDAQ:RCEL), VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, Interim Chief Executive Officer, and David O'Toole, Chief Financial Officer, on February 18,

CobbleStone Software is recognized by Theorem LegalTech Marketplace for outstanding performance in legal technology. CobbleStone Software, the award?winning provider of contract management solutions, today announced that it has been recognized as a Leader in the Annual Theorem LegalTech Awards, and further distinguished with Solution of the Year, Best Estimated ROI, Users Most Likely to Recommend,

AVITA Medical to Host Investor Webinar Briefing GlobeNewswire February 13, 2026 VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, Interim Chief Executive

(NASDAQ:QURE), PHILADELPHIA, Feb. 13, 2026 (GLOBE NEWSWIRE) — National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against uniQure N.V. (NASDAQ: QURE) (“uniQure” or the “Company”) on behalf of investors who purchased or otherwise acquired uniQure securities during the period from September 24, 2025 through October 31, 2025

Lilac Biosciences, a biotechnology company spun out of the Giuliani RNA Center at Brown University, developing quantitative RNA-based analytical tools, announced a research collaboration with Soin Neuroscience, a developer of neuromodulation technologies for chronic pain. The collaboration will investigate whether changes in RNA expression can serve as biological correlates of pain states and neuromodulation response.